Campo Mártires da Pátria, 130 1169-056 Lisboa PORTUGAL
Phone: 351218803000

Júlio César Rocha

Docente Professor Auxiliar
Júlio César Rocha is a Nutritionist, with a post graduate qualification in Clinical Nutrition from the Faculty of Nutrition and Food Sciences – University of Porto (UP) and he has also a PhD in Metabolism, at the Faculty of Medicine, UP. He is Assistant Professor at NOVA Medical School teaching in the field of Nutrition and Metabolism. He has been working in the field of inborn metabolic diseases since 2003. He is also Nutritionist member of the clinical team at the Reference Centre of Inherited Metabolic Diseases at Centro Hospitalar Universitário Lisboa Central and he is a researcher at CINTESIS (Center for Health Technology and Services Research). He is council member of the SSIEM (Society for the Study of Inborn Errors of Metabolism), Chair of the Dieticians Group of the SSIEM (SSIEM-DG) and President of the Portuguese Society of Clinical Nutrition and Metabolism. He is also member of the working group of the European Phenylketonuria Guidelines.
  • Rodrigues C, Pinto A, Faria A, Teixeira D, van Wegberg AMJ, Ahring K, Feillet F, Calhau C, MacDonald A, Moreira-Rosário A, Rocha JC. Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis. Nutrients. 2021 Sep 28;13(10):3443.
  • Kanufre V, Almeida MF, Barbosa CS, Carmona C, Bandeira A, Martins E, Rocha S, Guimas A, Ribeiro R, MacDonald A, Pinto A, Rocha JC. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations. Nutrients. 2021 Sep 6;13(9):3118.
  • Pena MJ, Costa R, Rodrigues I, Martins S, Guimarães JT, Faria A, Calhau C, Rocha JC, Borges N. Unveiling the Metabolic Effects of Glycomacropeptide. Int J Mol Sci. 2021 Sep 8;22(18):9731.
  • Rocha JC, Bausell H, Bélanger-Quintana A, Bernstein L, Gökmen-Özel H, Jung A, MacDonald A, Rohr F, van Dam E, Heddrich-Ellerbrok M. Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase. Mol Genet Metab Rep. 2021 May 25;28:100771.
  • Peres M, Almeida MF, Pinto ÉJ, Carmona C, Rocha S, Guimas A, Ribeiro R, Martins E, Bandeira A, MacDonald A, Rocha JC. Implementing a Transition Program from Paediatric to Adult Services in Phenylketonuria: Results After Two Years of Follow-Up with an Adult Team. Nutrients. 2021 Feb 28;13(3):799.
  • Pena MJ, Pinto A, de Almeida MF, de Sousa Barbosa C, Ramos PC, Rocha S, Guimas A, Ribeiro R, Martins E, Bandeira A, Dias CC, MacDonald A, Borges N, Rocha JC. Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective. Orphanet J Rare Dis. 2021 Feb 13;16(1):84.
  • Kraleva D, Evans S, Pinto A, Daly A, Ashmore C, Pointon-Bell K, Rocha JC, MacDonald A. Protein Labelling Accuracy for UK Patients with PKU Following a Low Protein Diet. Nutrients. 2020 Nov 10;12(11):3440.
  • Daly A, Evans S, Pinto A, Ashmore C, Rocha JC, MacDonald A. A 3 Year Longitudinal Prospective Review Examining the Dietary Profile and Contribution Made by Special Low Protein Foods to Energy and Macronutrient Intake in Children with Phenylketonuria. Nutrients. 2020 Oct 15;12(10):3153.
  • Daly A, Evans S, Pinto A, Jackson R, Ashmore C, Rocha JC, MacDonald A. The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria. Nutrients. 2020 Sep 4;12(9):2704.
  • Daly A, Evans S, Pinto A, Jackson R, Ashmore C, Rocha JC, MacDonald A. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria. Nutrients. 2020 Aug 14;12(8):2443.
  • Wood G, Evans S, Pointon-Bell K, Rocha JC, MacDonald A. Special Low Protein Foods in the UK: An Examination of Their Macronutrient Composition in Comparison to Regular Foods. Nutrients. 2020 Jun 25;12(6):1893.
  • Rocha JC, Calhau C, MacDonald A. Reply to Jakovac; Severity of COVID-19 infection in patients with phenylketonuria: is vitamin D status protective? Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E890-E891.
  • Cannet C, Pilotto A, Rocha JC, Schäfer H, Spraul M, Berg D, Nawroth P, Kasperk C, Gramer G, Haas D, Piel D, Kölker S, Hoffmann G, Freisinger P, Trefz F. Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation. Orphanet J Rare Dis. 2020 Feb 27;15(1):61.
  • Ilgaz F, Pinto A, Gökmen-Özel H, Rocha JC, van Dam E, Ahring K, Bélanger-Quintana A, Dokoupil K, Karabulut E, MacDonald A. Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis. Nutrients. 2019 Sep 3;11(9):2070.
  • Sollari Allegro Prize 2016 - Original Scientific Paper published in 2015
  • Honorable Mention. Publication: Pena MJ, Almeida MF, van Dam E, Ahring K, Bélanger-Quintana A, Dokoupil K, Gokmen-Ozel H, Lammardo AM, MacDonald A, Robert M, Rocha JC. Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile. Orphanet Journal of Rare Diseases (2015):10(1):162.